Skip to content
PICO Portalanswers from OpenAlex

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis

PaperCitations, authors & open-access status

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis is a paper indexed in PICO Portal from OpenAlex.

How many citations does Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis have?

PICO Portalcitation count

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis has 726 citations in the OpenAlex counts PICO Portal stores.

When was Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis published?

PICO Portalyear

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis has 2013 year in the PICO Portal index.

What is the open-access status of Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis?

PICO Portaloa status

Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis has bronze oa status in the PICO Portal index.

What is the DOI of Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis?

PICO Portaldoi

The DOI for Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis is on the source record.

What is the PMID of Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis?

PICO Portalpmid

The PMID for Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis is on the source record.

What is the OpenAlex record for Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis?

PICO Portalopenalex

The OpenAlex for Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial